A GLP-1 diet plan is the way a person eats while taking a GLP-1 drug such as semaglutide or tirzepatide; the drug labels call for a reduced-calorie diet but do not define a specific plan.
Food and timing rules by drug
| Drug | Form | Food and timing rule on the label | Source |
|---|---|---|---|
| Zepbound or Mounjaro (tirzepatide) | Weekly shot | Any time of day, with or without meals | [4] |
| Wegovy (semaglutide) | Weekly shot | Time of day can change without a dose adjustment | [3] |
| Wegovy pill (semaglutide) | Daily tablet | Take in the morning on an empty stomach with up to 4 oz of plain water; swallow whole; wait at least 30 minutes before food, other drinks or other oral medicines | [3] |
| Foundayo (orforglipron) | Daily tablet | With or without food; swallow whole, do not break, crush or chew | [2] |
The Wegovy pill rule matters most for daily routine: breakfast, coffee and morning medicines all wait at least 30 minutes [3]. See Wegovy pill cost, Foundayo and our guides to using tirzepatide and using semaglutide.
Eating when nausea and other stomach effects hit
Stomach and gut effects are the most common problems. On Zepbound, nausea affected 25% to 29% of people across doses, diarrhea 19% to 23%, vomiting 8% to 13% and constipation 11% to 17%, vs 8%, 8%, 2% and 5% on placebo [5]. On Wegovy 2.4 mg, nausea affected 44% and constipation 24%, vs 16% and 11% on placebo [3]. In SURMOUNT-1, most stomach effects were mild to moderate and happened mainly while the dose was going up [6].
The labels do not give a food list for these effects. Tell your prescriber if you cannot keep food or fluids down: both labels warn of acute kidney injury from fluid loss and of severe stomach and gut reactions [5][3]. Zepbound is not recommended for people with severe gastroparesis [5]. More detail is in GLP-1 side effects.
Protein and keeping muscle
Eating less means the body loses some lean mass with fat. In a SURMOUNT-1 substudy, about 25% of the weight lost on tirzepatide was lean mass and 75% was fat [7]. No label sets a protein target. We could not confirm the protein numbers in a 2025 joint nutrition advisory from four US obesity and nutrition groups by Oct 17, 2026, so we do not print them here. Ask your prescriber or a registered dietitian for a target, and read how to keep muscle on a GLP-1.
Medicines, meals and blood sugar
- Diabetes medicines. Low blood sugar is more likely with insulin or a sulfonylurea. In Zepbound's type 2 diabetes trial, 4.2% had low blood sugar below 54 mg/dL on tirzepatide vs 1.3% on placebo, and 10.3% of those also taking a sulfonylurea [5].
- Birth control pills. Tirzepatide can make oral hormonal birth control less effective. The label says to switch to a non-oral method or add a barrier method for 4 weeks after starting and after each dose increase [4]. Foundayo's label says the same for 30 days [2].
- Thyroid pills. With the Wegovy pill, levothyroxine exposure rose 33% in testing; the label advises monitoring oral drugs with a narrow safety range [3].
See tirzepatide interactions and semaglutide interactions.
Gallbladder, pancreas and surgery warnings
The Zepbound and Wegovy labels both warn of acute gallbladder disease and acute pancreatitis [5][3]. Severe stomach pain that will not go away needs a call to your prescriber right away. Both labels also warn that food or liquid can be breathed into the lungs during general anesthesia or deep sedation, so tell the care team you take the drug before any planned procedure [5][3].
After you stop the drug
In SURMOUNT-4, people switched from tirzepatide to placebo regained 14.0% of body weight from week 36 to 88, while those who stayed on it lost another 5.5% [8]. After stopping semaglutide in the STEP 1 extension, people regained 11.6 of 17.3 percentage points within a year [9]. No study in our sources tested a specific diet for keeping weight off after stopping. Brand guides: tirzepatide diet, semaglutide diet, Wegovy diet, Mounjaro diet, Ozempic diet.
What the drugs cost
| Drug | Self-pay price | What is included | Checked | Source |
|---|---|---|---|---|
| Wegovy pen | $349 a month ($199 for 0.25 or 0.5 mg on a new patient's first two fills) | Drug only, 4 pens | 2026-10-17 | [10] |
| Wegovy pill | $149 to $299 a month by dose | Drug only, 30 tablets | 2026-10-17 | [10] |
| Zepbound (LillyDirect) | $299 to $449 a month by dose; higher if a refill is more than 45 days late | Drug only | 2026-10-17 | [11] |
| Foundayo (LillyDirect) | $149 to $299 a month by dose | Drug only | 2026-10-17 | [12] |
Full price breakdowns are in GLP-1 cost. Some online programs bundle coaching with the prescription; compare them in best online GLP-1 programs.
When to call for help
Stop and call your prescriber for severe stomach pain that will not go away, which can be a sign of pancreatitis [5][3]. If you take insulin or a sulfonylurea, watch for low blood sugar [5]. These drugs carry a boxed warning for thyroid C-cell tumors seen in rodents; do not use them with a personal or family history of medullary thyroid carcinoma or MEN 2 [5][3]. Stop Zepbound or Wegovy when pregnancy is recognized, and stop semaglutide at least 2 months before a planned pregnancy [5][3]. For signs of a serious allergic reaction, call 911.
Questions people ask
Is there an official GLP-1 diet plan?
What should I eat on semaglutide?
The Wegovy label does not list foods. It does set rules for the Wegovy pill: take it on an empty stomach in the morning with up to 4 oz of plain water and wait at least 30 minutes before eating, drinking anything else or taking other oral medicines [3].
Can I take Zepbound or Mounjaro with food?
Yes. The tirzepatide labels say the weekly shot can be given any time of day, with or without meals [4].
How much protein do I need on a GLP-1?
No GLP-1 label sets a protein target. We could not confirm the protein numbers in the 2025 joint nutrition advisory as of Oct 17, 2026. In a SURMOUNT-1 substudy, about 25% of weight lost on tirzepatide was lean mass [7], so ask your prescriber or a registered dietitian for a target.
What should I eat when GLP-1 nausea hits?
Does a GLP-1 change blood sugar if I have diabetes?
Low blood sugar is more likely with insulin or a sulfonylurea. In Zepbound's type 2 diabetes trial, 4.2% had low blood sugar below 54 mg/dL vs 1.3% on placebo, rising to 10.3% with a sulfonylurea [5].
Sources
12 cited
- Zepbound (tirzepatide) label. DailyMed, National Library of Medicine, Aug 2026.
- Foundayo (orforglipron) tablets prescribing information. Eli Lilly and Company, Jul 2026.
- Wegovy (semaglutide) injection and tablets label. DailyMed, National Library of Medicine, Jun 2026.
- Mounjaro (tirzepatide) label. DailyMed, National Library of Medicine, Aug 2026.
- Zepbound (tirzepatide) injection prescribing information, revised 04/2026. US Food and Drug Administration, Apr 2026.
- Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine (PubMed record), Jun 4, 2022.
- Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study. Diabetes, Obesity and Metabolism (PubMed record), Feb 25, 2025.
- Continued treatment with tirzepatide for maintenance of weight reduction (SURMOUNT-4). JAMA (PubMed record), Jan 1, 2024.
- Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism (PubMed record), May 19, 2022.
- Wegovy self-pay offer. NovoCare Pharmacy (Novo Nordisk), Oct 17, 2026.
- Zepbound self-pay prices. LillyDirect (Eli Lilly and Company), Oct 17, 2026.
- Foundayo self-pay prices. LillyDirect (Eli Lilly and Company), Oct 17, 2026.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.